Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.92 |
| ▸ | TSHR | P16473 | 4/20 | 0.92 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.92 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.31 |
| ▸ | LDHB | P07195 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylamide SCHEMBL7161182 | 1.00 | — | — | |
| Acrylamide SCHEMBL8158838 | 1.00 | — | — | |
| Acrylamide SCHEMBL7163810 | 1.00 | ALDH1A1 (0.92) | ALDH1A1TSHRFGFR4LMNATDP1 | |
| Acrylamide SCHEMBL17685704 | 0.96 | ALDH1A1 (0.85) | ALDH1A1TSHRFGFR4LMNATDP1 | |
| Acrylamide SCHEMBL21001929 | 0.96 | — | — | |
| Acrylamide SCHEMBL4865873 | 0.96 | ALDH1A1 (0.85) | ALDH1A1TSHRFGFR4LMNATDP1 | |
| Acrylamide SCHEMBL183292 | 0.96 | TSHR (1.00) | ALDH1A1TSHRFGFR4LMNATDP1 | |
| Acrylamide SCHEMBL3051 | 0.96 | — | — | |
| Acrylamide SCHEMBL170034 | 0.96 | TSHR (1.00) | ALDH1A1TSHRFGFR4LMNATDP1 | |
| Acrylamide SCHEMBL1332245 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037834-A | Modified bonding composition for high-cold weather-resistant battery cell pole piece | 益阳长天新能源科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2025202518-A1 | MEASURE OF A QUINOLINATE AND TRYPTOPHAN CONCENTRATION | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-10-02 | — | — | WO | claimed |
| US-12378343-B2 | Silicone hydrogel composition and silicone hydrogel lens | PEGAVISION CORPORATION (TW) | 2025-08-05 | — | — | US | claimed |
| WO-2025097070-A1 | ORAL DOSAGE FORM WITH CATIONICALLY CHARGEABLE HYDROGEL FOR DELIVERY OF ACTIVE AGENT | ENTREGA INC. (US) | 2025-05-08 | — | — | WO | claimed |
| CN-119823468-A | Composite PE film based on modified graphene and preparation method thereof | 东莞市天加实业有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119431689-A | Preparation method of contact lenses and contact lenses thereof | 江苏海伦隐形眼镜有限公司 | 2025-02-14 | — | — | CN | claimed |
| US-20250017827-A1 | Acid-Stable Glass Fillers And Self-Adhesive Dental Composite Cements With Good Transparency Containing Them | IVOCLAR VIVADENT AG (LI) | 2025-01-16 | — | — | US | claimed |
| CN-119000831-A | CO based on hydrogel structure2Gas sensor, method for producing the same and use thereof | 华东理工大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118594275-A | Modification method of polymer film, modified polymer film and filtering device | 艾里奥斯生物科技(上海)有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-118434791-A | Silicone monomer, contact lens composition and contact lens | 晶硕光学股份有限公司 | 2024-08-02 | — | — | CN | claimed |
| EP-0716606-B1 | PHOSPHATE-BINDING POLYMERS FOR ORAL ADMINISTRATION | GELTEX PHARMA INC (US) | 2001-08-29 | — | — | EP | claimed |
| US-6264937-B1 | MIXTURE WITH LIPASE INHIBITOR | GELTEX PHARMACEUTICALS, INC. | 2001-07-24 | — | — | US | claimed |
| WO-2001049824-A2 | CELL GROWTH SUBSTRATE HYDROGELS | NOVARTIS AG (CH) | 2001-07-12 | — | — | WO | claimed |
| US-6203785-B1 | ADMINISTERING CROSSLINKED CATIONIC POLYMER ANTICHOLESTEROL AGENTS | GELTEX PHARMACEUTICALS, INC. | 2001-03-20 | — | — | US | claimed |
| WO-1999022743-A1 | POLY(DIALLYLAMINE)-BASED PHOSPHATE BINDERS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-05-14 | — | — | WO | claimed |
| WO-1998043653-A1 | INTERPENETRATING POLYMER NETWORKS FOR SEQUESTRATION OF BILE ACIDS | GELTEX PHARMACEUTICALS, INC. (US) | 1998-10-08 | — | — | WO | claimed |
| US-5397675-A | Alkali developable photosensitive resin composition containing oil-soluble diazo resin | NIPPON PAINT CO., LTD. (JP) | 1995-03-14 | — | — | US | claimed |
| EP-0581311-A2 | Alkali developable photosensitive resin composition | Nippon Paint Co., Ltd. (JP) | 1994-02-02 | — | — | EP | claimed |
| US-4537855-A | PHOTOPOLYMERIZABLE HIGH MOLECULAR WEIGHT COMPOUND HAVING POLYFUCTIONAL ETHYLENICALLY UNSATURATED SIDE CHAIN OR END GROUPS | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1985-08-27 | — | — | US | claimed |
| US-4112022-A | ACRYLATE OR AN ACRYLAMIDE | BORG-WARNER CORPORATION (US) | 1978-09-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250017827-A1 | Acid-Stable Glass Fillers And Self-Adhesive Dental Composite Cements With Good Transparency Containing Them | HAO2, HAO1, CDH1 | ALDH1A1 1494/4885TSHR 4061/4885FGFR4 3076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.